TipRanks
Go Ultimate55% OFF

Aquarius Surgical Technologies (AQQRF) AI Stock Analysis

AQQRF

Aquarius Surgical Technologies

(Other OTC:AQQRF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue ReboundThe 20.3% TTM revenue rebound provides evidence of renewed demand for the company’s surgical technologies and related solutions. If maintained, improving sales can broaden operating scale, support customer adoption, and create a stronger base for eventual cost absorption.
Negative Factors
Persistent UnprofitabilityThe extremely negative TTM net margin, together with ongoing EBIT and EBITDA losses, shows that revenue and gross profit are not covering the company’s operating and non-operating cost base. Persistent losses weaken internal funding capacity and make a durable earnings recovery uncertain.

Aquarius Surgical Technologies (AQQRF) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%AQQRF0.00%SPY+11.79%Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$115.92K
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.3
Beta (1Y)
-168.55
Revenue Growth
9.11%
EPS Growth
-596.49%
Country
US
Employees
3
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Aquarius Surgical Technologies Business Overview & Revenue Model

Company Description

Aquarius Surgical Technologies Inc., operating through its subsidiary Surgical Lasers Inc., specializes in the creation, sale, distribution, and promotion of advanced technological solutions tailored for surgical and other healthcare settings through...

Aquarius Surgical Technologies Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

AQQRF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:PRNTSE:PRN50NeutralCAD 335.37M-6.77-62.45%―59.60%32.53%
TSE:ASGTSE:ASG47NeutralCAD 8.98M-5.36-34.32%―-5.42%-5.37%
TSE:VPTTSE:VPT46NeutralCAD 15.43M-6.1356.40%―89.06%37.62%
TSE:PINKTSE:PINK38UnderperformCAD 27.62M-1.41-303.05%―35.27%58.34%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%150%AQQRFTSE:ASGTSE:PINKTSE:PRNTSE:VPTJan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
AQQRF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AQQRFAquarius Surgical Technologies 0.500.000.00%
TSE:ASGAurora Spine0.12-0.17-58.93%
TSE:PINKPerimeter Medical Imaging Ai Inc0.18-0.05-23.40%
TSE:PRNProfound Medical9.180.9111.00%
TSE:VPTVentriPoint Diagnostics0.08-0.02-20.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.